Maternal Exposure to Metformin Safe: Proves a Largest Cohort study

Published On 2022-04-01 13:13 GMT   |   Update On 2022-04-01 13:13 GMT

A recent study published in BMJ Open Diabetes Research and Care, aimed to investigate if maternal pregnancy exposure to metformin is associated with increased risk of long-term and short-term adverse outcomes in the child.Study was conducted in Finland included singleton children born 2004–2016 with maternal pregnancy exposure to metformin or insulin,3967 participants were given metformin...

Login or Register to read the full article

A recent study published in BMJ Open Diabetes Research and Care, aimed to investigate if maternal pregnancy exposure to metformin is associated with increased risk of long-term and short-term adverse outcomes in the child.

Study was conducted in Finland included singleton children born 2004–2016 with maternal pregnancy exposure to metformin or insulin,3967 participants were given metformin only , 5273 insulin only and 889 combination treatment.

The primary outcomes were long-term offspring obesity, hypoglycemia, hyperglycemia, diabetes, hypertension, polycystic ovary syndrome, and challenges in motor social development.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News